A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Participants With Early Alzheimer's Disease
Clinical trial NCT02880956 · COMPLETED
Trial details
- NCT number
- NCT02880956
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-26
- Primary completion
- 2021-03-30
- Enrollment
- 453
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.